期刊文献+

组织因子、组织因子途径抑制物与妇科肿瘤术后深静脉血栓形成的关系 被引量:3

Relationship between Plasma Tissue Factor and Tissue Factor Pathway Inhibitor and Gynecologic Tumors Patients with Postoperative Deep Venous Thrombosis
暂未订购
导出
摘要 目的检测妇科肿瘤术后下肢深静脉血栓形成的患者血浆中组织因子(TF)、组织因子途径抑制物(TFPI-1)水平的变化,探讨其与妇科肿瘤术后深静脉血栓形成的相关性。方法用ELISA法分别检测妇科良恶性肿瘤术后患者血浆TF、TFPI-1水平的变化。结果无深静脉血栓形成的妇科恶性肿瘤组TF水平显著高于子宫肌瘤及健康对照组(P<0.01),妇科恶性肿瘤组TFPI-1水平高于子宫肌瘤及健康对照组(P<0.05),子宫肌瘤与健康对照组比较差异无统计学意义(P>0.05)。深静脉血栓形成妇科恶性肿瘤组TF水平显著高于子宫肌瘤及健康对照组(P<0.01),有深静脉血栓形成妇科恶性肿瘤组TFPI-1水平与无深静脉血栓形成妇科恶性肿瘤组相比之间无统计学差异(P>0.05),子宫肌瘤与健康对照组比较差异无统计学意义(P>0.05)。结论妇科肿瘤术后深静脉血栓形成患者组织因子明显增高,TF、TFPI-1可作为检测妇科肿瘤尤其是妇科恶性肿瘤术后深静脉血栓形成的重要指标。 Objective To investigate the relationship between tissue factor (TF),tissue factor pathway inhibitor (TFPI-1) and postoperative deep venous thrombosis in patients with gynecological tumors by measuring the plasma levels of TF and TFPI-1. Methods Seventy two patients with gynecological tumors were enrolled and the plasma levels of TF and TFPI-1 antigen were measured by ELISA method. Results Of no deep vein thrombosis groups, the plasma levels of TF in gynecological tumors group were significantly higher than that of uterine myomas and healthy controls (P 〈 0.01 ), gynecological tumors group TFPI-1 levels were higher than that of uterine myomas and healthy control group ( P 〈 0.05 ), uterine myomas compared with the healthy control group were no significant difference ( P 〉 0.05 ). Of deep vein thrombosis groups, TF of gynecological malignant tumor group were significantly higher than that of uterine myomas group and the healthy control group ( P 〈 0.01 ), TFPI-1 levels of deep vein thrombosis with gynecological malignant tumors and no deep vein thrombosis of gynecological malignant tumor group were no significant difference ( P 〉 0.05 ), TFPI-1 level were no significantly difference between uterine myomas and healthy control group (P 〉 0.05 ). Conclusion TF and TFPI-1 of gynecologic tumors patients with postoperative deep venous thrombosis are significantly higher, and they can be used as indicators for gynecologic malignant gynecological tumors, especially postoperative deep venous thrombosis.
出处 《中国现代医生》 2011年第25期61-62,66,共3页 China Modern Doctor
关键词 组织因子 组织因子途径抑制物 妇科肿瘤 深静脉血栓形成 Tissue factor Tissue factor pathway inhibitor Gynecologic tumor Deep venous thrombosis
  • 相关文献

参考文献7

  • 1Korte W. Cancer and thrombosis: an increasingly important association[J].Support Care Cancer, 2008,16 ( 3 ) : 223-228.
  • 2Groebke Zbinden K, Banner DW, Ackermann J, et al. Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors[J]. Bioorg Med Chem Lett,2005,15 ( 3 ) : 817-822.
  • 3Maiolo A, Tua A, Grignani G. Hemostasis and cancer: tumor cells induce the expression of tissue factor-like procoagulant activity on endothelial cells[J]. Haematologica, 2002,87 ( 6 ) : 624-628.
  • 4Mousa SA, Bozarth J, Barrett JS. Pharmacodynamie properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects[J]. J Clin Pharmacol,2003,43 ( 7 ): 727-734.
  • 5van Stralen K J, Rosendaal FR, Doggen CJ. Minor injuries as a risk factor for venous thrombosis[J]. Arch Intern Med,2008,168 ( 1 ) : 21-26.
  • 6Levine MN, Lee AY, Kakkar AK. Thrombosis and cancer[M]. Alexandria, VA : American Society of Clinical Oncology, 2005 : 748.
  • 7陈萍.妇科肿瘤术后并发下肢深静脉血栓形成的临床研究[J].中国医药导报,2010,7(19):250-251. 被引量:19

二级参考文献6

共引文献18

同被引文献16

  • 1邹红燕,赵晓利,姚安梅,王平.以顺铂为基础的不同化疗方案在宫颈癌同步放化疗中的疗效[J].现代肿瘤医学,2006,14(1):83-85. 被引量:9
  • 2曹泽毅.妇科常见恶性肿瘤诊断与治疗规范[M]北京:人民卫生出版社,200054.
  • 3Tan L,Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer-the Addenbrooke's Experience[J].Clinical Oncology(royal College of Radiologists),2008,(05):358-364.
  • 4Ohno T,Kato S,Wakatsuki M. Incidence and temporal pattern of anorexia,diarrhea,weight loss,and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin:comparison with radiation therapy alone[J].Gynecologic Oncology,2006,(01):94-99.
  • 5Yang L,Parkin DM,Li LD. Estimation and projection of the rational profile of cancer mortality in China:1991-2005[J].British Journal of Cancer,2008,(11):2157-2166.
  • 6Amaral JF. The experimental development of an ultrasonically activated scalpel for laparoscopic use[J].Surgical Laparoscopy Endoscopy,1994,(02):92.
  • 7Martíndel JC,Blanco JI,Carbajo MA. Laparoscopic appendectomy by ultrasonically activated scalpel in acute appendicitis:preliminary report[J].Journal of Laparoendoscopic & Advanced Surgical Techniques Part A,2002,(02):111.
  • 8Korte W. Cancer and thrombosis:an increasingly important association [J]. Support Care Cancer,2008,16(3) :223 N228.
  • 9Uno K, Homma S, Satoh T, et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer [ J ]. Br J Cancer, 2007,96:290 - 295.
  • 10Hernandez C, Orbe J, Roncal C, et al. Tissue factor expressed by mi- croparticles is associated with mortality but not with thrombosis in cancer patients [ J ]. Thromb Haemost ,2013,110:598 - 608.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部